Диссертация (1173261), страница 18
Текст из файла (страница 18)
– №36(11). – P. 1089–104.92.Devinsky, O. Recognizing and preventing epilepsy–related mortality: Acall for action. / O. Devinsky, T. Spruill, D. Thurman, D. Friedman. // Neurology. –2016 Feb. – №86(8). – P. 779–86.93.Dibbens, L.M. Familial and sporadic 15q13.3 microdeletions in idiopathicgeneralized epilepsy: precedent for disorders with complex inheritance. / L.M. Dibbens,S. Mullen, I. Helbig, H.C.
Mefford, M.A. Bayly, S. Bellows, C. Leu, H. Trucks, T.Obermeier, M. Wittig, A. Franke, H. Caglayan, Z. Yapici, T. Sander, E.E. Eichler, I.E.Scheffer , J.C. Mulley, S.F. Berkovic. // Hum Mol Genet. – 2009 Oct. – №18(19). – P.3626–31.94.Donati, F. The cognitive effects of oxcarbazepine versus carbamazepine orvalproate in newly diagnosed children with partial seizures. / F Donati, G.
Gobbi, J.Campistol, G. Rapatz, M. Daehler, Y. Sturm, A.P. Aldenkamp // Seizure. – 2007 Dec. –№16(8). – P. 670–9.95.Edefonti, V. Health–related quality of life in adults with epilepsy: the effectof age, age at onset and duration of epilepsy in a multicentre Italian study. / V. Edefonti,F.
Bravi, K. Turner, E. Beghi, M.P. Canevini, M. Ferraroni, A. Piazzini // BMC Neurol.– 2011. – №11. – P. 33.11596.Engel, J. A proposed diagnostic scheme for people with epileptic seizuresand with epilepsy: report of the ILAE Task Force on Classification and Terminology. /J. Engel // Epilepsia. – 2001. – Vol. 42. – P.
796–803.97.Elaine, C. A Population–Based Study of Long–term Outcomes ofCryptogenic Focal Epilepsy in Childhood: Cryptogenic Epilepsy is NOT ProbablySymptomatic Epilepsy. / C. Elaine, А. Wirrell, B.R. Grossardt, L. Elson, K.C. Nickels //Epilepsia. – 2011 Apr. – №52(4). – P. 738–745.98.Ferrillo, F. Sleep EEG synchronization mechanisms and activation ofinterictal epileptic spikes. / F. Ferrillo, M. Beelke, L. Nobili // Clin Neurophysiol. –2000 Sep.
– №111. – Suppl 2. – P. 65–73.99.Finegersh, A. Bilateral hippocampal atrophy in temporal lobe epilepsy:Effect of depressive symptoms and febrile seizures. / A. Finegersh, C. Avedissian, S.Shamim, I. Dustin, P.M. Thompson, W.H. Theodore // Epilepsia. – 2011 Apr. –№52(4).
– P. 689–697.100. Fisher, R.S. Epileptic seizures and epilepsy: definitions proposed by theInternational League Against Epilepsy (ILAE) and the International Bureau for Epilepsy(IBE). / R.S. Fisher, W. van Emde Boas, W. Blume [et al.] // Epilepsia. – 2005. – №46– P. 470–472.101. Fisher, R.S. A practical clinical definition of epilepsy. / R.S. Fisher, C.Acevedo, A. Arzimanoglou [et al.] // Epilepsia. – 2014. – №55 – P.
475–482.102. Foldvary–Schaefer, N. Sleep and epilepsy. / N. Foldvary–Schaefer, M.Grigg–Damberger // Semin Neurol. – 2009. – №29. – P. 419–28.103. Gaillard, W.D. Guidelines for imaging infants and children with recent–onset epilepsy. / W.D.
Gaillard , C. Chiron , J.H. Cross, A.S. Harvey, R. Kuzniecky [etal.] // Epilepsia. – 2009 Sep. – №50(9). – P. 2147–53.104. Geerts, A. Onset of intractability and its course over time: the Dutch studyof epilepsy in childhood. / A. Geerts, O. Brouwer, H. Stroink, C. van Donselaar, B.Peters, E. Peeters [et al.] // Epilepsia. – 2012. – №53. – P. 741–51.116105. Genton, P. Progress in pharmaceutical development presentationwith improved pharmacokinetics: a new formulation for valproate. / P.
Genton //Acta Neurol. Scand. – 2005. – Vol. 182 (Suppl.). – P. 26–32.106. Gholami, A. Quality of life in epileptic patients compared with healthypeople. / A. Gholami, S. Salarilak, P. Lotfabadi, F. Kiani, A. Rajabi, K. Mansori, M.Zahra // Med J Islam Repub Iran. – 2016. – №30. – P. 388.107. Gilliam, F. Patient–validated content of epilepsy–specific quality–of–lifemeasurement.
/ F. Gilliam, R. Kuzniecky, E. Faught [et al.] // Epilepsia. – 1997. –№38(2). – P. 233–236.108. Gilliam, F. Optimizing health outcomes in active epilepsy. / F. Gilliam //Neurology. – 2002. – №58 (Suppl 5). – P. 9–20.109. Gilliam, F. Depression in epilepsy: ignoring clinical expression of neuronalnetwork dysfunction? / F. Gilliam, J. Santos, V. Vahle, J.
Carter, K. Brown, H.Hecimovic // Epilepsia. – 2004. – №45. – P. 28–34.110. Glauser, Т. ILAE treatmentguidelines: evidence–based analysis ofantiepileptic drug efficacyand effectiveness as initial monotherapy for epileptic seizuresandsyndromes. / Т. Glauser, E. Ben–Menachem, B. Bourgeois [et al.] // Epilepsia. –2006. – Vol. 47. – P. 1094–1120.111. Gomer, B.
The influence of antiepileptic drugs on cognition: a comparisonof levetiracetam with topiramate. / B. Gomer, K. Wagner, L. Frings, J. Saar, A. Carius,M. Härle, B.J. Steinhoff, A. Schulze–Bonhage // Epilepsy Behav. – 2007 May. –№10(3). – P. 486–94.112. Guekht, A. The epidtmiology of epilepsy in the Russian Federation. / A.Guekht, W.A. Hauser, L. Milchakova, Y. Churillin, A. Shpak, E. Gusev. // EpilepsyRes. – 2010 Dec. – №92 (2–3). – P.
209–18.113. Hatzenbuehler, M.L. Stigma as a fundamental cause of population healthinequalities. / M.L. Hatzenbuehler, J.C. Phelan, G. Bruce // Am J Public Health. – 2013May. – №103(5). – P. 813–21.114. Hauser, W.A. Recent development in epidemiology of epilepsy. / W.A.Hauser // Acta Neurolog. Scandinavica.
– 1995. – Suppl. 162. – P. 17–21.117115. Hays, R.D. The RAND 36–item health survey 1.0. / R.D. Hays, C.Sherbourne, E. Mazel // Health Econ. – 1993. – №2. – P. 217–27.116. Hee–Jin, I.M. Associations of impaired sleep quality, insomnia, andsleepiness with epilepsy: A questionnaire based case–control study. / I. M.
Hee–Jin, P.Seong–Ho, B. Shin–Hye [et al.] // Epilepsy & Behavior. – 2016 Apr. – V. 57. – P. 55–59.117. Helmstaedter, C. Cognitive outcome of antiepileptic treatment withlevetiracetam versus carbamazepine monotherapy: a non–interventional surveillancetrial. / C. Helmstaedter, J.A. Witt // Epilepsy Behav. – 2010 May. – №18(1–2). – P. 74–80.118. Hermann, B.P. Psychiatric comorbidity in chronic epilepsy: identification,consequences, and treatment of major depression.
/ B.P. Hermann, M. Seidenberg, B.Bell // Epilepsia. – 2000. – №41(Suppl. 2). – P. 31–41.119. Hesdorffer, D.C. Major depression is a risk factor for seizures in olderpatients. / D.C. Hesdorffer, W.A. Hauser, J.F. Annegers, G. Cascino // Ann Neurol. –2000. – №47. – P. 246–249.120. Hesdorffer, D.C. Epilepsy, suicidality, and psychiatric disorders: abidirectional association. / D.C.
Hesdorffer, L. Ishihara, L. Mynepalli, D.J. Webb, J.Weil, W.A. Hauser. // Ann Neurol. – 2012. – №72. – P. 184–191.121. Hirsch, E. Antiepileptic drug–induced pharmacodynamic aggravation ofseizures: does valproate have a lower potential? / E. Hirsch, P. Genton // CNS Drugs. –2003. – Vol. 17.
– P. 633–640.122. Hecimovic, H. Severe hippocampal atrophy is not associated withdepression in temporal lobe epilepsy. / H.Hecimovic, J. Santos, J.L. Price, Y.I. Sheline,F.G. Gilliam. // Epilepsy and Behavior. – 2014 May. – Volume 34. – P. 9–14.123. Jacoby, A. Measuring the impact of epilepsy: the development of a novelscale. / A. Jacoby, G.A. Baker, D. Smith [et al.] // Epilepsy Res. – 1993. – №16.Volume 1. – P.
83–88.118124. Jacoby, A. The clinical course of epilepsy and psychological correlates:finding from a UK community study. / A. Jacoby, G.A. Baker, N. Steen [et al.] //Epilepsia. – 1996. – №37. – P. 148–161.125. Jacoby, A. Quality of life trajectories in epilepsy: a review of the literature./ A. Jacoby, G.A. Baker // Epilepsy Behav. – 2008 May.
– №12(4). – P. 557–71.126. Jacoby, A. Felt versus enacted stigma: A concept revisited: Evidence froma study of people with epilepsy in remission. / A. Jacoby // Soc Sci Med. – 1994. –№38. – P. 269–74.127. Jacoby, A. Self–reported anxiety and sleep problems in people withepilepsy and their association with quality of life. / A. Jacoby, D. Snape, S. Lane, G.A.Baker // Epilepsy Behav. – 2015 Feb. – №43. – P. 149–58.128. Janz, D. Epilepsy with impulsive petit mal (juvenile myoclonic epilepsy). /D.
Janz // Acta Neurol. Scand. – 1985. – V.72. – P. 349–359.129. Jedrzejczak, J. An observational study of first–line valproate monotherapyin focal epilepsy. / J. Jedrzejczak, M. Kuncíková, S. Magureanu. // Eur J Neurol. – 2008Jan. – №15(1). – P. 66–72.130. Kaae, S.S.
Quantitative hippocampal structural changes followingelectroconvulsive seizure treatment in a rat model of depression. / S.S Kaae, F. Chen, G.Wegener, T.M. Madsen, J.R. Nyengaard // Synapse. – 2012 Aug. – №66(8). – P. 667–76.131. Kanner, A.M. Depression and epilepsy: a review of multiple facets of theirclose relation. / A.M.
Kanner // Neurol Clin. – 2009. – №27. – P. 865–80.132. Kanner, A.M. Depression in epilepsy: prevalence, clinical semiology,pathogenic mechanisms, and treatment. / A.M. Kanner // Biol Psychiatry. – 2003. –№54. – P. 388–98.133. Kanner, A.M. Anxiety disorders, subsyndromic depressive episodes, andmajor depressive episodes: do they differ on their impact on the quality of life ofpatients with epilepsy? / A.M.
Kanner, J.J. Barry, F. Gilliam, B. Hermann, K.J. Meador// Epilepsia. – 2010 Jul. – №51(7). – P. 1152–8.119134. Kanner, A.M. Can neurobiological pathogenic mechanisms of depressionfacilitate the development of seizure disorders? / A.M. Kanner // Lancet Neurol. – 2012Dec. – №11(12). – P. 1093–102.135. Karlov, V.A. What is cryptogenic epilepsy? / V.A. Karlov, S.N.Illarioshkin, G.A. Kovalenko, N. Abramycheva, M. Krotenkova, E. Kremneva, O.Inozemtseva // 31th Epilepsy Congress Istanbul.
– 2015 5–9 September. – Abstract. –App store. – P. 1078.136. Khatami, R. Sleepwake habits and disorders in a series of 100 adultepilepsy patients – a prospective study. / R. Khatami, D. Zutter, A. Siegel, J. Mathis, F.Donati, C.L. Bassetti. // Seizure. – 2006. – №15. – P. 299–306.137. Kokkonen, J. Psychosocial outcome of young adults with epilepsy inchildhood. / J. Kokkonen, E.R. Kokkonen, A.L. Saukkonen, P. Pennanen // J NeurolNeurosurg Psychiatry. – 1997. – №62. – P. 265–268.138. Konishi, Т. Partial seizures duringthe course in patients with absenceepilepsy. / Т.
Konishi, J. Matsuzawa, K. Hongou [et al.] // To Hattatsu. – 1999. – Vol.31. – P. 395–401.139. Koponen, A. Social Functioning and Psychological Well Being of 347Young Adults with Epilepsy Only – Population Based, Controlled Study from Finland. /A. Koponen, U.